SEDANS logo

Sedana Medical BATS-CHIXE:SEDANS Stock Report

Last Price

kr15.79

Market Cap

kr2.6b

7D

0%

1Y

n/a

Updated

14 Jun, 2024

Data

Company Financials +

Sedana Medical AB (publ)

BATS-CHIXE:SEDANS Stock Report

Market Cap: kr2.6b

SEDANS Stock Overview

A medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally.

SEDANS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Sedana Medical AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sedana Medical
Historical stock prices
Current Share Pricekr15.79
52 Week Highkr0
52 Week Lowkr0
Beta0.26
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-11.64%

Recent News & Updates

Recent updates

Shareholder Returns

SEDANSGB Medical EquipmentGB Market
7D0%-1.1%-1.8%
1Yn/a-9.6%4.2%

Return vs Industry: Insufficient data to determine how SEDANS performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how SEDANS performed against the UK Market.

Price Volatility

Is SEDANS's price volatile compared to industry and market?
SEDANS volatility
SEDANS Average Weekly Movementn/a
Medical Equipment Industry Average Movement6.9%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.8%

Stable Share Price: SEDANS has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine SEDANS's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199983Johannes Dollwww.sedanamedical.com

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; and Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care, as well as AnaConDa, a medical device enabling administration of inhaled anaesthetics. It also provides FlurAbsorb and FlurAbsorb-S, which are active carbon filters to capture waste anaesthetic gases from the exhaust of the ventilator; Scavenging tube, a one piece pre-connected tube designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; FlurAbsorb mount to hold the FlurAbsorb during scavenging of anesthetic gas; FlurAbsorb-S mount to hold the FlurAbsorb-S during scavenging of anesthetic gas; FlurAbsorb accessory kit comprising accessories to connect the exhaust of the ventilator and the gas monitor to the FlurAbsorb/FlurAbsorb-S; and Mindray exhaust connector, which enables to connect the exhaust of the ventilator to an active or passive scavenging system.

Sedana Medical AB (publ) Fundamentals Summary

How do Sedana Medical's earnings and revenue compare to its market cap?
SEDANS fundamental statistics
Market capkr2.60b
Earnings (TTM)-kr22.83m
Revenue (TTM)kr164.91m

15.8x

P/S Ratio

-113.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SEDANS income statement (TTM)
Revenuekr164.91m
Cost of Revenuekr48.65m
Gross Profitkr116.26m
Other Expenseskr139.09m
Earnings-kr22.83m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 23, 2024

Earnings per share (EPS)-0.23
Gross Margin70.50%
Net Profit Margin-13.85%
Debt/Equity Ratio0%

How did SEDANS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.